Cargando…

Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer

Oxaliplatin resistance is a challenge in the treatment of colorectal cancer (CRC) patients. Regulatory T cells (Tregs) are well known for their immunosuppressive roles, and targeting Tregs is an effective way to improve chemosensitivity. Exosome-delivered microRNA (miRNA) might be used as a potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Ning, Tao, Li, Jialu, He, Yi, Zhang, Haiyang, Wang, Xinyi, Deng, Ting, Liu, Rui, Li, Hongli, Bai, Ming, Fan, Qian, Zhu, Kegan, Ying, Guoguang, Ba, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417448/
https://www.ncbi.nlm.nih.gov/pubmed/33905821
http://dx.doi.org/10.1016/j.ymthe.2021.04.028
_version_ 1783748382709252096
author Ning, Tao
Li, Jialu
He, Yi
Zhang, Haiyang
Wang, Xinyi
Deng, Ting
Liu, Rui
Li, Hongli
Bai, Ming
Fan, Qian
Zhu, Kegan
Ying, Guoguang
Ba, Yi
author_facet Ning, Tao
Li, Jialu
He, Yi
Zhang, Haiyang
Wang, Xinyi
Deng, Ting
Liu, Rui
Li, Hongli
Bai, Ming
Fan, Qian
Zhu, Kegan
Ying, Guoguang
Ba, Yi
author_sort Ning, Tao
collection PubMed
description Oxaliplatin resistance is a challenge in the treatment of colorectal cancer (CRC) patients. Regulatory T cells (Tregs) are well known for their immunosuppressive roles, and targeting Tregs is an effective way to improve chemosensitivity. Exosome-delivered microRNA (miRNA) might be used as a potential biomarker for predicting chemosensitivity. However, the relationship between Tregs and exosomal miRNAs remains largely unknown. TaqMan low-density array was performed to screen the differentially expressed serum miRNAs from pooled serum of patients who had FOLFOX treatment. Differential expression was validated using qRT-PCR in individual samples. Exosomes were isolated by sequential differential centrifugation, and they were verified by transmission electron microscopy. The RNA and protein levels were determined by quantitative real-time PCR and western blotting. A mouse xenograft model was adopted to evaluate the correlation between exosome-derived miR-208b and Tregs in vivo. We demonstrated that circulating miR-208b is a non-invasive marker for predicting FOLFOX sensitivity in CRC. miR-208b in colon cancer was secreted by tumor cells in the pattern of exosomes, and oxaliplatin-resistant cells showed the most obvious phenomenon of miR-208b increase. Colon cancer cell-secreted miR-208b was sufficiently delivered into recipient T cells to promote Treg expansion by targeting programmed cell death factor 4 (PDCD4). Furthermore, in vivo studies indicated that Treg expansion mediated by cancer cell-secreted miR-208b resulted in tumor growth and oxaliplatin resistance. Our results demonstrate that tumor-secreted miR-208b promotes Treg expansion by targeting PDCD4, and it may be related to a decrease of oxaliplatin-based chemosensitivity in CRC. These findings highlight a potential role of exosomal miR-208b as a predictive biomarker for oxaliplatin-based therapy response, and they provide a novel target for immunotherapy.
format Online
Article
Text
id pubmed-8417448
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society of Gene & Cell Therapy
record_format MEDLINE/PubMed
spelling pubmed-84174482022-09-01 Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer Ning, Tao Li, Jialu He, Yi Zhang, Haiyang Wang, Xinyi Deng, Ting Liu, Rui Li, Hongli Bai, Ming Fan, Qian Zhu, Kegan Ying, Guoguang Ba, Yi Mol Ther Original Article Oxaliplatin resistance is a challenge in the treatment of colorectal cancer (CRC) patients. Regulatory T cells (Tregs) are well known for their immunosuppressive roles, and targeting Tregs is an effective way to improve chemosensitivity. Exosome-delivered microRNA (miRNA) might be used as a potential biomarker for predicting chemosensitivity. However, the relationship between Tregs and exosomal miRNAs remains largely unknown. TaqMan low-density array was performed to screen the differentially expressed serum miRNAs from pooled serum of patients who had FOLFOX treatment. Differential expression was validated using qRT-PCR in individual samples. Exosomes were isolated by sequential differential centrifugation, and they were verified by transmission electron microscopy. The RNA and protein levels were determined by quantitative real-time PCR and western blotting. A mouse xenograft model was adopted to evaluate the correlation between exosome-derived miR-208b and Tregs in vivo. We demonstrated that circulating miR-208b is a non-invasive marker for predicting FOLFOX sensitivity in CRC. miR-208b in colon cancer was secreted by tumor cells in the pattern of exosomes, and oxaliplatin-resistant cells showed the most obvious phenomenon of miR-208b increase. Colon cancer cell-secreted miR-208b was sufficiently delivered into recipient T cells to promote Treg expansion by targeting programmed cell death factor 4 (PDCD4). Furthermore, in vivo studies indicated that Treg expansion mediated by cancer cell-secreted miR-208b resulted in tumor growth and oxaliplatin resistance. Our results demonstrate that tumor-secreted miR-208b promotes Treg expansion by targeting PDCD4, and it may be related to a decrease of oxaliplatin-based chemosensitivity in CRC. These findings highlight a potential role of exosomal miR-208b as a predictive biomarker for oxaliplatin-based therapy response, and they provide a novel target for immunotherapy. American Society of Gene & Cell Therapy 2021-09-01 2021-04-24 /pmc/articles/PMC8417448/ /pubmed/33905821 http://dx.doi.org/10.1016/j.ymthe.2021.04.028 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Ning, Tao
Li, Jialu
He, Yi
Zhang, Haiyang
Wang, Xinyi
Deng, Ting
Liu, Rui
Li, Hongli
Bai, Ming
Fan, Qian
Zhu, Kegan
Ying, Guoguang
Ba, Yi
Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer
title Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer
title_full Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer
title_fullStr Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer
title_full_unstemmed Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer
title_short Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer
title_sort exosomal mir-208b related with oxaliplatin resistance promotes treg expansion in colorectal cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417448/
https://www.ncbi.nlm.nih.gov/pubmed/33905821
http://dx.doi.org/10.1016/j.ymthe.2021.04.028
work_keys_str_mv AT ningtao exosomalmir208brelatedwithoxaliplatinresistancepromotestregexpansionincolorectalcancer
AT lijialu exosomalmir208brelatedwithoxaliplatinresistancepromotestregexpansionincolorectalcancer
AT heyi exosomalmir208brelatedwithoxaliplatinresistancepromotestregexpansionincolorectalcancer
AT zhanghaiyang exosomalmir208brelatedwithoxaliplatinresistancepromotestregexpansionincolorectalcancer
AT wangxinyi exosomalmir208brelatedwithoxaliplatinresistancepromotestregexpansionincolorectalcancer
AT dengting exosomalmir208brelatedwithoxaliplatinresistancepromotestregexpansionincolorectalcancer
AT liurui exosomalmir208brelatedwithoxaliplatinresistancepromotestregexpansionincolorectalcancer
AT lihongli exosomalmir208brelatedwithoxaliplatinresistancepromotestregexpansionincolorectalcancer
AT baiming exosomalmir208brelatedwithoxaliplatinresistancepromotestregexpansionincolorectalcancer
AT fanqian exosomalmir208brelatedwithoxaliplatinresistancepromotestregexpansionincolorectalcancer
AT zhukegan exosomalmir208brelatedwithoxaliplatinresistancepromotestregexpansionincolorectalcancer
AT yingguoguang exosomalmir208brelatedwithoxaliplatinresistancepromotestregexpansionincolorectalcancer
AT bayi exosomalmir208brelatedwithoxaliplatinresistancepromotestregexpansionincolorectalcancer